Clofazimine Inhalation Suspension Fast Tracked for NTM Lung Disease
Clofazimine is an antibiotic that inhibits mycobacterial growth and binds preferentially to mycobacterial DNA.
Source: empr.com
Michael Castagna News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Castagna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Castagna Today - Breaking & Trending Today
MannKind Repays Certain Debt Obligations
Credit and security agreement with MidCap Financial Trust repaid in full for approximately $31.6 millionConvertible note issued to Mann Group LLC repaid in exchange for 1.5 million shares of common...
Source: marketscreener.com
MannKind Announces CFO Transition
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem...
Source: businessinsider.com
MannKind caps off record year with Q4 earnings beat | Pacific Coast Business Times
MannKind employees including CEO Michael Castagna, center, ring the opening bell of the Nasdaq on May 23. (courtesy photo) Westlake Village-based MannKind Corporation capped off a record year with a fourth quarter to remember, beating analysts' estimates and setting up for a brighter future. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary
Source: pacbiztimes.com
Wedbush Weighs in on MannKind Co.'s Q2 2024 Earnings (NASDAQ:MNKD)
MannKind Co. (NASDAQ:MNKD – Free Report) – Analysts at Wedbush issued their Q2 2024 earnings estimates for shares of MannKind in a research report issued to clients and investors on Wednesday, February 28th. Wedbush analyst A. Argyrides forecasts that the biopharmaceutical company will post earnings of $0.02 per share for the quarter. Wedbush currently has […]
Source: dailypolitical.com